Fundacion Biomedica Galicia Sur
- Address
- Carretera Clara Campoamor 341, Bloque Tecnico Planta 2
Sponsor Overview
Specializations
Cardiovascular medicine
Research activity is centered on severe symptomatic aortic stenosis and its management in the setting of transcatheter aortic valve implantation (TAVI), with attention to post-procedural antiplatelet therapy and related cardiovascular outcomes.
- Aortic valve disease
- Transcatheter aortic valve implantation
- Post-TAVI antithrombotic treatment
The sponsor’s clinical interest includes balancing protection from thrombotic events with the risk of bleeding in older and high-risk cardiac populations.
Thrombotic and bleeding risk management
Funding is directed toward comparing ticagrelor and aspirin in the prevention of net adverse clinical events, reflecting a focus on both ischemic protection and hemorrhagic safety after valve intervention.
- Antiplatelet therapy
- Stroke prevention
- Bleeding complications
Clinical outcomes of interest include transient ischemic attack, myocardial infarction, and procedure-related vascular events.
Ischemic and vascular complications
The research portfolio addresses complications affecting the cerebrovascular, coronary, and peripheral arterial systems, including recurrent angina, valve thrombosis, claudication, and acute limb ischemia.
- Cerebrovascular events
- Coronary ischemia
- Peripheral arterial ischemia
These interests place emphasis on the broader vascular consequences associated with structural heart disease treatment.
Multicenter cardiovascular collaboration
Clinical research is conducted through a broad network of collaborating sites across multiple countries, supporting study activity in interventional cardiology and valvular heart disease.
- Multinational site collaboration
- Valvular intervention research
- Cardiovascular outcomes assessment
The sponsor’s functional identity as a Cardiovascular Research Unit is reflected in its concentration on post-procedural cardiac and vascular safety.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Ticagrelor Versus Acetylsalicylic Acid for Single Antiplatelet Therapy Post-Transcatheter Aortic Valve Implantation in Severe Symptomatic Aortic Stenosis |  Italy Portugal Spain | Recruiting |
| Intraoperative Target-Controlled Infusion of Sufentanil versus Standard Fentanyl for 24‑hour Postoperative Analgesia in Urgent Laparoscopic Cholecystectomy | Spain | Not Yet Recruiting |
Data & Insights
This sponsor works with 4 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 32 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
- 2.Digestive System Diseases1 trial280 other sponsors
Partnered Research Centres
32 centres- Address
- Via Santa Sofia 78, 95123 Catania
- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
- Address
- Praceta Professor Mota Pinto, 3004-561 Coimbra
- Address
- Alameda Professor Hernani Monteiro, 4200-319 Porto
- Address
- Estrada Clara Campoamor N 341, 36312 Vigo
- Address
- Estrada Clara Campoamor No 341, 36312 Vigo
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Fundacion Biomedica Galicia Sur.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.